Kolmar BNH’s HemoHIM gets dual recognition for fatigue improvement, immune enhancement
Kolmar BNH confirmed dual functionality of HemoHIM for immune enhancement and fatigue improvement.
Kolmar BNH confirmed dual functionality of HemoHIM for immune enhancement and fatigue improvement
It is the first health-functional food in Korea to be individually approved for immune function improvement.
Atomy, a Korean partner company, markets the product in Korea, while also exporting it to over 20 countries, including the U.S. and China.
The company has been conducting research since 2017 after it saw the possibility of HemoHIM’s efficacy in fatigue improvement.
Clinical trials and non-clinical trials revealed significant improvements in the Fatigue Severity Scale (FSS) and Multidimensional Fatigue Inventory (MFI) when healthy adult men and women aged between 30 and 60 consumed the HemoHIM.
The clinical trial results were published in Phytomedicine Plus, an academic journal focusing on natural medical products, with the company registering related patents in Korea and Russia.
Kolmar BNH plans to continue in-depth research on the HemoHIM to secure additional global intellectual property rights.
Kolmar BNH said that HemoHIM is unique in securing both immune function enhancement and fatigue improvement functionalities among individually approved ingredients. The company added that it plans to accelerate its approach to the global market with this differentiated ingredient.
Website: https://shop.atomy.com/
Contact
ATOMY
Park Kyung Tae Manager
070-5121-0281
Send Email
This news is a press release provided by ATOMY. Korea Newswire follows these editorial guidelines.
